Seattle Genetics About
Seattle Genetics Seattle Genetics is a biotechnology company
focused on developing monoclonal antibody (mAb)-based therapeutics for cancer
and immunologic diseases. PIPELINE SGN-30
is a genetically engineered antibody targeting the CD30 antigen, which is expressed
on many types of hematologic malignancies such as Hodgkin's disease and some types
of non-Hodgkin's lymphoma. SGN-15 is an antibody-drug conjugate
(ADC) composed of a genetically engineered antibody targeted to an antigen that
is conjugated to doxorubicin.A phase II clinical trial has been completed using
SGN-15 for the treatment of non-small cell lung cancer in combination with
Taxotere. SGN-40 is a humanized antibody targeted to the CD40 antigen
-- target sites are hematologic malignancies such as multiple myeloma and
non-Hodgkin's lymphoma. Key
Statistics for Seattle Genetics
Basic
Chart for Seattle Genetics